CRL Charles River Laboratories
NYSE · SEC CIK 1100682 · EDGAR
- Bought, last 12 months
- $4,364 1 purchases by 1 insiders
- Sold, last 12 months
- $42.61M 10 sales by 6 insiders
- Filings on record
- 278 since 2021-08-10, latest 2026-08-27 16:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| FOSTER JAMES C | Dir | — | $34.84M |
| Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| Creamer Victoria L | EVP, CHRO | — | $1.08M |
| Andrews Nancy C | Dir | — | $163.4K |
| LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| Mintz Mark | EVP, CIO | — | — |
| Kemps-Polanco Reshema | Dir | — | — |
| Barg Steven | Dir | — | — |
Transactions 404
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-10 | 2021-06-09 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -252 | 4,371 | -5% | $0 |
| M | 2021-08-10 | 2021-08-06 | CRL | FOSTER JAMES C | COB, Pres, CEO, Dir | S - Sale | $401.79 | -10.0K | 208.5K | -5% | -$4.02M |
| 2021-08-10 | 2021-08-06 | CRL | FOSTER JAMES C | COB, Pres, CEO, Dir | G - Gift | $0.00 | -2,500 | 212.3K | -1% | $0 | |
| M | 2021-08-10 | 2021-08-09 | CRL | Smith David Ross | CFO, Corp. Executive VP | S - Sale | $407.40 | -1,750 | 14.4K | -11% | -$713.0K |
Purchase Sale Sale after option exercise All abbreviations